Taysha Gene Therapies
TSHA
TSHA
193 hedge funds and large institutions have $1.48B invested in Taysha Gene Therapies in 2025 Q4 according to their latest regulatory filings, with 63 funds opening new positions, 62 increasing their positions, 46 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
35% more repeat investments, than reductions
Existing positions increased: 62 | Existing positions reduced: 46
25% more funds holding
Funds holding: 154 → 193 (+39)
1.16% more ownership
Funds ownership: 97% → 98.17% (+1.2%)
Holders
193
Holding in Top 10
6
Calls
$7.02M
Puts
$2.12M
Top Buyers
| 1 | +$40.1M | |
| 2 | +$18.1M | |
| 3 | +$17.3M | |
| 4 |
PCH
Polar Capital Holdings
London,
United Kingdom
|
+$12.8M |
| 5 |
BlackRock
New York
|
+$11.1M |
Top Sellers
| 1 | -$38.6M | |
| 2 | -$16.8M | |
| 3 | -$12.9M | |
| 4 |
JFG
Jefferies Financial Group
New York
|
-$10.4M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
-$9.71M |
